Notably, individuals from two families carrying germline variants in BRCA and BRIP1 exhibited a spectrum of malignancies, including esophageal cancer, renal cancer, ovarian cancer, laryngeal cancer, and lung cancer. This evidence concerns the gene BRIP1 and ovarian cancer.